Aurinia Pharmaceuticals (AUPH) had the highest return in 2013 by a small-cap US stock, returning 5,088.9%.
| ASSET | YEAR | % RETURN |
|---|---|---|
Aurinia Pharmaceuticals (AUPH) | 2013 | 5,088.91% |
Canadian Solar (CSIQ) | 2013 | 752% |
Gray Television (GTN.A) | 2013 | 609.35% |
Xpel (XPEL) | 2013 | 592.97% |
Gray Television (GTN) | 2013 | 552.65% |
Himax Technologies (HIMX) | 2013 | 535.74% |
BioCryst Pharmaceuticals (BCRX) | 2013 | 377.99% |
Daqo New Energy Corp ADR (DQ) | 2013 | 353.75% |
JinkoSolar (JKS) | 2013 | 346.64% |
Clearfield (CLFD) | 2013 | 341.92% |
Old Second Bancorp (OSBC) | 2013 | 269.58% |
Nu Skin Enterprises (NUS) | 2013 | 269.53% |
Aehr Test Systems (AEHR) | 2013 | 255.17% |
Prothena (PRTA) | 2013 | 253.6% |
Celldex Therapeutics (CLDX) | 2013 | 251.38% |
Universal Insurance (UVE) | 2013 | 246.24% |
Independent Bank (IBCP) | 2013 | 241.88% |
Stagwell (STGW) | 2013 | 240.09% |
ReposiTrak (TRAK) | 2013 | 237.54% |
Methode Electronics (MEI) | 2013 | 236.22% |
Vanda Pharmaceuticals (VNDA) | 2013 | 228.31% |
Pacira BioSciences (PCRX) | 2013 | 223.7% |
Eyepoint Pharmaceuticals (EYPT) | 2013 | 222.76% |
Safe Bulkers (SB) | 2013 | 217.51% |
Shutterstock (SSTK) | 2013 | 217.14% |
Small-cap stocks are treated as having a market cap between $300M and $2B.
